| Revised response criteria for malignant lymphoma BD Cheson, B Pfistner, ME Juweid, RD Gascoyne, L Specht, SJ Horning, ... Journal of clinical oncology 25 (5), 579-586, 2007 | 5410 | 2007 |
| A prognostic score for advanced Hodgkin's disease D Hasenclever, V Diehl, JO Armitage, D Assouline, M Björkholm, ... New England Journal of Medicine 339 (21), 1506-1514, 1998 | 2268 | 1998 |
| Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage … A Gallamini, M Hutchings, L Rigacci, L Specht, F Merli, M Hansen, C Patti, ... Journal of clinical oncology 25 (24), 3746-3752, 2007 | 1045 | 2007 |
| FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma M Hutchings, A Loft, M Hansen, LM Pedersen, T Buhl, J Jurlander, S Buus, ... Blood 107 (1), 52-59, 2006 | 937 | 2006 |
| Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial J Overgaard, HS Hansen, L Specht, M Overgaard, C Grau, E Andersen, ... The Lancet 362 (9388), 933-940, 2003 | 830 | 2003 |
| A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish … J Overgaard, HS Hansen, M Overgaard, L Bastholt, A Berthelsen, ... Radiotherapy and Oncology 46 (2), 135-146, 1998 | 725 | 1998 |
| Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis P Warde, L Specht, A Horwich, T Oliver, T Panzarella, M Gospodarowicz, ... Journal of clinical oncology 20 (22), 4448-4452, 2002 | 717 | 2002 |
| Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG) L Specht, J Yahalom, T Illidge, AK Berthelsen, LS Constine, HT Eich, ... International Journal of Radiation Oncology* Biology* Physics 89 (4), 854-862, 2014 | 618 | 2014 |
| Early positron emission tomography response–adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial MPE André, T Girinsky, M Federico, O Reman, C Fortpied, M Gotti, ... Journal of Clinical Oncology 35 (16), 1786-1794, 2017 | 532 | 2017 |
| Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines T Girinsky, R van der Maazen, L Specht, B Aleman, P Poortmans, ... Radiotherapy and Oncology 79 (3), 270-277, 2006 | 447 | 2006 |
| Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation JJ Thorn, HS Hansen, L Specht, L Bastholt Journal of oral and maxillofacial surgery 58 (10), 1088-1093, 2000 | 404 | 2000 |
| Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group J Yahalom, T Illidge, L Specht, RT Hoppe, YX Li, R Tsang, A Wirth, ... International Journal of Radiation Oncology* Biology* Physics 92 (1), 11-31, 2015 | 386 | 2015 |
| Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography–staged treatment-naive patients with Hodgkin lymphoma TC El-Galaly, F d'Amore, KJ Mylam, P de Nully Brown, M Bøgsted, A Bukh, ... Journal of clinical oncology 30 (36), 4508-4514, 2012 | 348 | 2012 |
| Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold AN Pedersen, S Korreman, H Nyström, L Specht Radiotherapy and oncology 72 (1), 53-60, 2004 | 338 | 2004 |
| Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique SS Korreman, AN Pedersen, TJ Nøttrup, L Specht, H Nyström Radiotherapy and oncology 76 (3), 311-318, 2005 | 336 | 2005 |
| Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma M Hutchings, A Loft, M Hansen, LM Pedersen, AK Berthelsen, S Keiding, ... haematologica 91 (4), 482-489, 2006 | 330 | 2006 |
| Surveillance following orchidectomy for stage I seminoma of the testis H von der Maase, L Specht, GK Jacobsen, A Jakobsen, EL Madsen, ... European journal of cancer 29 (14), 1931-1934, 1993 | 324 | 1993 |
| Modern radiation therapy for nodal non-Hodgkin lymphoma—target definition and dose guidelines from the International Lymphoma Radiation Oncology Group T Illidge, L Specht, J Yahalom, B Aleman, AK Berthelsen, L Constine, ... International Journal of Radiation Oncology* Biology* Physics 89 (1), 49-58, 2014 | 311 | 2014 |
| Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3 … L Specht, RG Gray, MJ Clarke, R Peto Journal of Clinical Oncology 16 (3), 830-843, 1998 | 295 | 1998 |
| The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer CB Lajer, E Garnæs, L Friis-Hansen, B Norrild, MH Therkildsen, M Glud, ... British journal of cancer 106 (9), 1526-1534, 2012 | 292 | 2012 |
Ivan VogeliusClinical Professor at Dept. of Oncology, Rigshospitalet & Faculty of Health Sciences, CopenhagenDirección de correo verificada de regionh.dk
